XML 37 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Cash Flows - USD ($)
4 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:          
Net loss   $ (72,227,000) $ (76,774,000) $ (94,718,000) $ (79,550,000)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   1,929,000 1,712,000 2,316,000 1,494,000
Change in fair value of warrants and SAFE liabilities   12,562,000 24,379,000 24,471,000 12,488,000
Write-down of inventories   4,393,000 64,000 1,378,000 3,486,000
Loss on disposal of property and equipment   30,000 37,000 37,000 188,000
Loss on extinguishment of debt   866,000 6,124,000 6,124,000 0
Share-based compensation   4,710,000 1,856,000 2,702,000 2,062,000
Loss on write off of property and equipment   359,000   0 0
Changes in operating assets and liabilities          
Accounts receivable   723,000 (74,000) 805,000 (364,000)
Inventories   (3,206,000) (1,880,000) (2,454,000) (6,054,000)
Other current assets   (3,571,000) (1,072,000) 179,000 (874,000)
Other long-term assets   544,000 (13,000) (2,000) (887,000)
Accounts payable   2,462,000 (1,154,000) (431,000) 454,000
Accrued liabilities   2,606,000 1,383,000 (550,000) (820,000)
Other current liabilities   279,000 142,000 102,000 36,000
Other long-term liabilities   (190,000) (127,000) (160,000) 1,252,000
Net cash provided by/(used in) operating activities   (47,731,000) (45,398,000) (60,201,000) (67,089,000)
Cash flows from investing activities:          
Purchase of marketable securities   (123,403,000)   (6,908,000) 0
Proceeds from maturities of marketable securities   8,465,000      
Proceeds from sale of marketable securities   4,448,000   249,000  
Purchase of property and equipment   (1,981,000) (1,122,000) (1,487,000) (4,388,000)
Proceeds from disposal of property and equipment   18,000 368,000 368,000 0
Net cash used in investing activities   (112,453,000) (754,000) (7,778,000) (4,388,000)
Cash flows from financing activities:          
Settlement of SAFE notes     (5,609,000) (5,609,000) 0
Principal payments on financing obligations   (11,206,000) (6,968,000) (9,540,000) (4,556,000)
Proceeds from the issuance of debt   31,910,000   0 5,940,000
Proceeds from issuance of SAFE notes     37,377,000 37,377,000 66,468,000
Principal payments on capital leases   (159,000) (64,000) (118,000) (15,000)
Proceeds from issuance of Convertible Preferred stock       68,666,000 0
Proceeds from issuance of restricted common stock     61,000 61,000 84,000
Financing costs paid for debt   (361,000) (5,367,000) (5,367,000) 0
Issuance cost paid for Series X Preferred stock   (5,662,000)      
Payment made for merger related expense   (707,000)      
Repurchase of Common Stock   (11,000) (11,000) (13,000) (2,000)
Proceeds from sale of Private Placement Warrants to Sponsor       46,000,000  
Net cash provided by financing activities   183,804,000 88,085,000 85,457,000 67,919,000
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents   23,620,000 41,933,000 17,478,000 (3,558,000)
Beginning cash and cash equivalents and restricted cash and cash equivalents   27,305,000 9,827,000 9,827,000 13,385,000
Ending cash and cash equivalents and restricted cash and cash equivalents $ 9,827,000 50,925,000 51,760,000 27,305,000 9,827,000
Supplemental disclosures of cash flow information:          
Cash paid for interest   2,013,000 1,652,000 2,018,000 2,220,000
Cash paid for income taxes       0 1,000
Noncash Investing and Financing Items [Abstract]          
Conversion of Bridge Note to Series A Convertible Preferred stock     7,719,000 7,719,000 0
Conversion of SAFE notes into common stock     4,925,000 4,925,000 0
Conversion of SAFE notes into Series A Convertible Preferred stock     173,726,000 173,726,000 0
Assets acquired on capital leases   43,000 430,000 397,000 79,000
Purchases of property and equipment recorded in accounts payable and accrued liabilities   313,000 79,000 150,000 249,000
Merger related expense recorded in accounts payable and accrued liabilities   3,669,000      
Issuance cost for Series X preferred stock recorded in accounts payable   227,000      
Gores Metropoulos, Inc.          
Cash flows from operating activities:          
Net loss (21,985) (3,378,457) 4,261,643 5,445,176  
Changes in operating assets and liabilities          
Accrued liabilities 335,418 2,882,693 (294,056) (282,215)  
Changes in state franchise tax accrual 1,431 (170,000) 148,569 198,569  
Changes in prepaid assets and deferred costs   76,939 (193,429) (136,399)  
Changes in deferred offering costs (437,375)   437,375 437,375  
Changes in current income tax and interest payable   (969,658) 497,951 1,102,662  
Changes in deferred income tax   2,353 293,594 (2,353)  
Net cash provided by/(used in) operating activities (122,511) (1,556,130) 5,151,647 6,762,815  
Cash flows from investing activities:          
Cash deposited in Trust Account     (400,000,000) (400,000,000)  
Interest reinvested in Trust Account   709,764 (4,738,939) (6,434,959)  
Net cash used in investing activities   709,764 (404,738,939) (406,434,959)  
Cash flows from financing activities:          
Proceeds from notes and advances payable - related party 150,000        
Proceeds from sale of Class F common stock to Sponsor 25,000        
Proceeds from sale of Units in initial public offering   400,000,000 400,000,000 400,000,000  
Proceeds from sale of Private Placement Warrants to Sponsor     10,000,000 10,000,000  
Repayment of notes and advances payable – related party     (150,000) (150,000)  
Payment of underwriters' discounts and commissions     (8,000,000) (8,000,000)  
Payment of accrued offering costs     (865,105) (865,105)  
Net cash provided by financing activities 175,000   400,984,895 400,984,895  
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents 52,489 (846,366) 1,397,603 1,312,751  
Beginning cash and cash equivalents and restricted cash and cash equivalents   1,365,240 52,489 52,489  
Ending cash and cash equivalents and restricted cash and cash equivalents $ 52,489 518,874 1,450,092 1,365,240 $ 52,489
Supplemental disclosures of cash flow information:          
Deferred Underwriting Compensation     14,000,000 14,000,000  
Cash paid for income taxes   1,459,136 342,729    
Cash paid for income and state franchise taxes       342,729  
Series A Redeemable Convertible Preferred Stock          
Cash flows from financing activities:          
Proceeds from issuance of Convertible Preferred stock     $ 68,666,000    
Series X Redeemable Convertible Preferred Stock          
Cash flows from financing activities:          
Proceeds from issuance of Convertible Preferred stock   $ 170,000,000   $ 170,000,000